Lucis
Lucis offers preventive-health analysis using more than 110 blood biomarkers and personalized AI-generated insights.
$20MSeries A
Role not disclosedS
Singular
Activity from announced rounds
Activity in this selectionOct 23, 2026 · Consumer · Jan 1, 2026
Singular is the European venture firm whose official portfolio lists Restate, Apoha and Basecamp Research.
Recorded funding activity
Restate supplies durable execution for software. Apoha measures molecular behavior, while Basecamp develops biological models. These records identify the firm separately from unrelated products and managers called Singular.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $32.8M 2 disclosed · full round size, not this investor’s share